Fig. 6From: Real-world safety analysis of deutetrabenazine post-marketing: a disproportionality study leveraging the FDA Adverse Event Reporting System (FAERS) databaseSignal Strength of top 20 AEs of deutetrabenazine at the PT Level in FAERS DatabaseBack to article page